Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 Dec;39(6):781–783. doi: 10.1136/gut.39.6.781

Treating Helicobacter pylori--the best is yet to come?

A Harris 1, J J Misiewicz 1
PMCID: PMC1383446  PMID: 9038656

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axon A. T. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol. 1991 Mar-Apr;6(2):131–137. doi: 10.1111/j.1440-1746.1991.tb01452.x. [DOI] [PubMed] [Google Scholar]
  2. Banatvala N., Davies G. R., Abdi Y., Clements L., Rampton D. S., Hardie J. M., Feldman R. A. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut. 1994 Nov;35(11):1562–1566. doi: 10.1136/gut.35.11.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell G. D., Bate C. M., Axon A. T., Tildesley G., Kerr G. D., Green J. R., Emmas C. E., Taylor M. D. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther. 1995 Oct;9(5):513–520. doi: 10.1111/j.1365-2036.1995.tb00414.x. [DOI] [PubMed] [Google Scholar]
  4. Bell G. D., Powell K., Burridge S. M., Pallecaros A., Jones P. H., Gant P. W., Harrison G., Trowell J. E. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther. 1992 Aug;6(4):427–435. doi: 10.1111/j.1365-2036.1992.tb00556.x. [DOI] [PubMed] [Google Scholar]
  5. Digestive Disease Week and the 95th Annual Meeting of the American Gastroenterological Association. New Orleans, Louisiana, May 15-18, 1994. Abstracts. Gastroenterology. 1994 Apr;106(4 Suppl):A1–1198. [PubMed] [Google Scholar]
  6. Graham D. Y., Lew G. M., Malaty H. M., Evans D. G., Evans D. J., Jr, Klein P. D., Alpert L. C., Genta R. M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992 Feb;102(2):493–496. doi: 10.1016/0016-5085(92)90095-g. [DOI] [PubMed] [Google Scholar]
  7. Jaup B. H., Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol. 1995 Jun;90(6):943–945. [PubMed] [Google Scholar]
  8. Kuipers E. J., Lundell L., Klinkenberg-Knol E. C., Havu N., Festen H. P., Liedman B., Lamers C. B., Jansen J. B., Dalenback J., Snel P. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996 Apr 18;334(16):1018–1022. doi: 10.1056/NEJM199604183341603. [DOI] [PubMed] [Google Scholar]
  9. Labenz J., Stolte M., Rühl G. H., Becker T., Tillenburg B., Sollböhmer M., Börsch G. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1995 Jan;7(1):9–11. [PubMed] [Google Scholar]
  10. Lind T., Veldhuyzen van Zanten S., Unge P., Spiller R., Bayerdörffer E., O'Morain C., Bardhan K. D., Bradette M., Chiba N., Wrangstadh M. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter. 1996 Sep;1(3):138–144. doi: 10.1111/j.1523-5378.1996.tb00027.x. [DOI] [PubMed] [Google Scholar]
  11. Logan R. P., Gummett P. A., Schaufelberger H. D., Greaves R. R., Mendelson G. M., Walker M. M., Thomas P. H., Baron J. H., Misiewicz J. J. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut. 1994 Mar;35(3):323–326. doi: 10.1136/gut.35.3.323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moayyedi P., Sahay P., Tompkins D. S., Axon A. T. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol. 1995 Sep;7(9):835–840. [PubMed] [Google Scholar]
  13. The British Society of Gastroenterology spring meeting 20-22 March 1996. Abstracts. Gut. 1996;38 (Suppl 1):A1–73. [PMC free article] [PubMed] [Google Scholar]
  14. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  15. de Boer W. A., Driessen W. M., Jansz A. R., Tytgat G. N. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol. 1995 Dec;7(12):1189–1194. doi: 10.1097/00042737-199512000-00011. [DOI] [PubMed] [Google Scholar]
  16. de Boer W., Driessen W., Jansz A., Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet. 1995 Apr 1;345(8953):817–820. doi: 10.1016/s0140-6736(95)92962-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES